Latest DEF 14A proxy statements

WideOpenWest, Inc. provides an update on its proposed acquisition by DigitalBridge and Crestview Partners, confirming the definitive proxy statement filing and setting a December 3, 2025, shareholder meeting for the merger vote.

Jack in the Box Inc. announced the appointment of Mark King and Alan Smolinisky as independent directors to its Board, expanding it to 10 members, following a cooperation agreement with GreenWood Investors, LLC.

AmpliTech Group, Inc. issued a supplement to its definitive proxy statement to correct a typographical error regarding the number of outstanding common shares for its upcoming annual meeting.

Organovo Holdings, Inc. announced its 2023 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, an employee stock purchase plan, and a corporate charter amendment.

Hologic, Inc. announced robust fiscal fourth-quarter results with significant revenue and EPS growth, alongside a definitive agreement to be acquired by Blackstone and TPG for up to $79 per share.

TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, outlining key proposals including director elections, executive compensation, auditor ratification, and an increase in authorized common stock.

Permian Basin Royalty Trust unit holders to vote on a proposal to reform the Trust Indenture at a special meeting on December 16, 2025.

THOR Industries, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on December 17, 2025, outlining key proposals including director elections, auditor ratification, executive compensation, and an amended equity plan.

PB Bankshares, Inc. will merge with Norwood Financial Corp in an 80% stock, 20% cash transaction, unanimously recommended by PB Bankshares' board.

Streamex Corp. announced Nasdaq approval for continued listing and will reconvene a special shareholder meeting on November 4, 2025, to vote on an acquisition proposal.

Metsera, Inc. issued a statement refuting Pfizer's litigation, asserting it is an attempt to lower the acquisition price amidst a competing proposal from Novo Nordisk.

Surge Components, Inc. announces its Annual Meeting of Stockholders on November 25, 2025, to elect directors, ratify auditors, and extend its stockholder rights plan.

Greenwich LifeSciences, Inc. announced its 2025 Annual Meeting of Stockholders to elect directors and ratify its independent accounting firm, alongside detailed executive compensation and corporate governance updates.

High Income Securities Fund announces its Annual Meeting of Shareholders on December 15, 2025, to elect six Trustees and address other business.

Kindly MD, Inc. is holding its 2025 Annual Meeting to vote on key proposals including the re-election of directors, a strategic conversion to a Delaware corporation, and the ratification of its independent auditor.

374Water Inc. is calling a Special Meeting of Stockholders to vote on a reverse stock split aimed at regaining compliance with Nasdaq's minimum bid price requirement and facilitating future financing.

VivoSim Labs, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 16, 2025, where key proposals include director elections, auditor ratification, and advisory votes on executive compensation.

N2OFF, Inc. announced its annual stockholder meeting to vote on director elections, a significant increase in its share incentive plan, and an advisory vote on director share grants.

TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, to vote on director elections, executive compensation, auditor ratification, and a significant increase in authorized common stock.

THOR Industries reports $258.6 million net income and $577.9 million cash from operations in Fiscal Year 2025, increasing its dividend despite a prolonged RV industry downcycle.

Transcontinental Realty Investors, Inc. announces its Annual Meeting of Stockholders for December 10, 2025, to elect directors and ratify its independent accounting firm.

Leap Therapeutics, Inc. is seeking stockholder approval for proposals including an increase in authorized shares, a reverse stock split, a new equity incentive plan, and the potential issuance of over 19.99% of common stock upon warrant exercise.

CompoSecure, Inc. plans a strategic combination with Husky Technologies Limited, creating a diversified industrial compounder valued at approximately $7.36 billion.

CompoSecure, Inc. announced a proposed combination with Husky Technologies Limited, seeking shareholder approval for the issuance of shares to facilitate the transaction and related private placements.

InMed Pharmaceuticals Inc. announces its 2025 Annual General and Special Meeting to be held virtually on December 17, 2025, seeking shareholder approval for director elections, auditor appointment, and a significant share issuance under a standby equity purchase agreement.

Heidrick & Struggles International, Inc. stockholders are invited to a special meeting on December 5, 2025, to vote on a $59.00 per share all-cash merger agreement with affiliates of Advent International and Corvex PE Advisors.

Greenpro Capital Corp. announces its annual meeting on November 26, 2025, for informational purposes, with key corporate actions already approved by majority stockholder consent.

Guess?, Inc. announced that the Hart-Scott-Rodino antitrust waiting period for its merger with Authentic Brands Group LLC has expired, moving the company closer to becoming privately held.

International Endeavors Corp. announced a name change to ModuLink Inc. and an increase in authorized common stock from 4 billion to 6 billion shares, approved by its Board and majority stockholders.

Leap Therapeutics calls a special meeting to approve a significant share increase, a potential reverse stock split for Nasdaq compliance, and a new equity plan, following a $58.88 million private placement led by Winklevoss Capital.